A retrospective study to evaluate real-world persistence with and adherence to emicizumab treatment for persons with hemophilia A on prophylaxis
Latest Information Update: 10 Jan 2021
At a glance
- Drugs Emicizumab (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- 10 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology